
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
REGULUS THER.COMPAR DL001 7RG0 US75915K3095 BAW/UFN
© 2025 Xetra Newsboard
Realtime | Geld | Brief | Zeit |
---|---|---|---|
6,850 | 7,150 | 24.05. | |
6,850 | 7,050 | 23.05. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
08.05. | Regulus Therapeutics Inc. - 10-Q, Quarterly Report | ||
08.05. | Regulus Therapeutics Inc.: Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates | Entered into an agreement to be acquired by Novartis for $7.00 per share in cash, with potential to receive an additional $7.00 per share in cash through a contingent... ► Artikel lesen | |
01.05. | Novartis to expand renal disease pipeline with $1.7bn Regulus acquisition | ||
01.05. | Novartis to strengthen renal disease portfolio with Regulus | ||
01.05. | Regulus: SD-Dauerbrenner mit +888% in 3 Monaten | Über 30 Mal wurde die Aktie von Regulus Therapeutics (WKN: A3DNZ4) im Vorfeld der gestern verkündeten Übernahme durch Novartis in unserer sharedealsPlus-Community besprochen. Wer das Papier der Biotechfirma... ► Artikel lesen |